Australia is experience potentially transformative therapy for obesity: Retatrutide. The dual agonist – working on both GLP-1 and GIP receptors – has significant results in clinical research, indicating meaningful reductions in body fat. While regulatory clearance hasn't occurred with TGA, a number of individuals struggling being overweight mig… Read More